We are live on ! Find out more
AI

AdvisorShares Investments Portfolio holdings

AUM $549M
1-Year Est. Return 32.58%
This Fund
S&P 500
This Quarter Est. Return
-6.16%
1 Year Est. Return
+32.58%
3 Year Est. Return
+93.4%
5 Year Est. Return
+34.9%
10 Year Est. Return
AUM
$370M
AUM Growth
+$11.1M
Cap. Flow
+$50.7M
Cap. Flow %
13.7%
Top 10 Hldgs %
60.9%
Holding
357
New
127
Increased
63
Reduced
75
Closed
44

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 9.47%
2 Real Estate 9.17%
3 Healthcare 6.62%
4 Industrials 6.08%
5 Energy 5.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PARA
176
DELISTED
Paramount Global Class B
PARA
$388K 0.1%
+20,370
New +$489K
TPR icon
177
Tapestry
TPR
$33.3B
$388K 0.1%
+13,648
New +$456K
CHDN icon
178
Churchill Downs
CHDN
$6.02B
$387K 0.1%
+4,200
New +$428K
RLMD icon
179
Relmada Therapeutics
RLMD
$484M
$387K 0.1%
+10,458
New +$290K
GPI icon
180
Group 1 Automotive
GPI
$3.16B
$386K 0.1%
+2,700
New +$463K
PFSI icon
181
PennyMac Financial
PFSI
$3.94B
$384K 0.1%
+8,962
New +$468K
PMT
182
PennyMac Mortgage Investment
PMT
$818M
$384K 0.1%
+32,592
New +$476K
QNTM
183
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$22.1M
$380K 0.1%
6,962
+2,242
+48% +$132K
ROCC
184
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$378K 0.1%
+12,018
New +$423K
CE icon
185
Celanese
CE
$4.88B
$377K 0.1%
+4,176
New +$459K
OLN icon
186
Olin
OLN
$2.15B
$376K 0.1%
+8,760
New +$444K
ITCI
187
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$376K 0.1%
+8,076
New +$422K
SLVM icon
188
Sylvamo
SLVM
$1.6B
$373K 0.1%
+11,000
New +$418K
WSM icon
189
Williams-Sonoma
WSM
$29.5B
$372K 0.1%
+6,316
New +$448K
NUE icon
190
Nucor
NUE
$62.5B
$370K 0.1%
+3,462
New +$434K
SBGI icon
191
Sinclair Inc
SBGI
$995M
$368K 0.1%
+20,370
New +$452K
NMRK icon
192
Newmark Group
NMRK
$2.52B
$365K 0.1%
+45,324
New +$467K
SAGE
193
DELISTED
Sage Therapeutics
SAGE
$362K 0.1%
+9,232
New +$357K
CNTY icon
194
Century Casinos
CNTY
$33.8M
$353K 0.1%
53,761
+40,495
+305% +$312K
DRUG
195
Bright Minds Biosciences
DRUG
$793M
$351K 0.09%
57,056
-859
-1% -$5.57K
EAF icon
196
GrafTech
EAF
$205M
$351K 0.09%
+8,148
New +$518K
X
197
DELISTED
US Steel
X
$351K 0.09%
+19,352
New +$414K
GHRS icon
198
GH Research
GHRS
$2.03B
$349K 0.09%
30,056
+5,221
+21% +$65.9K
BTI icon
199
British American Tobacco
BTI
$123B
$341K 0.09%
9,617
+6,500
+209% +$260K
ENVB icon
200
Enveric Biosciences
ENVB
$6.2M
$331K 0.09%
435
+296
+213% +$373K

Similar funds

AdvisorShares Investments's Q3 2022 Portfolio in Review

As of Q3 2022, AdvisorShares Investments held 357 positions worth $370M, up 3.1% from $359M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

AdvisorShares Investments deployed $50.7M of net new capital in Q3 2022, opening 127 new positions and adding to 63 existing holdings. Its largest new stake was Occidental Petroleum: 23,042 shares worth $1.42M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 9.5% of assets, up from 7.8% a quarter earlier, followed by Real Estate and Healthcare.

On the sell side, the largest reduction was Invesco S&P 500 Low Volatility ETF, an estimated $45M trimmed.

  • AdvisorShares Investments's largest Q3 2022 buy was Occidental Petroleum: 23,042 shares worth $1.42M.
  • AdvisorShares Investments added most to Invesco S&P 500 Equal Weight ETF in Q3 2022, an estimated $43.1M increase.
  • AdvisorShares Investments's biggest Q3 2022 reduction was Invesco S&P 500 Low Volatility ETF, cutting an estimated $45M.
  • AdvisorShares Investments fully exited RYTHM Inc in Q3 2022, selling an estimated $1.92M.
  • AdvisorShares Investments's ten largest holdings make up 61% of its $370M portfolio in Q3 2022.
  • AdvisorShares Investments opened 127 new positions and closed 44 in Q3 2022.
  • AdvisorShares Investments's portfolio value rose 3.1% quarter-over-quarter to $370M.

Based on AdvisorShares Investments's 13F filing for Q3 2022, filed 14 Nov 2022.